ImageneBio Inc (IMA)

• Market cap: $67.8M
• 1 day: 0.33%
• 5 days: 10.68%
• 1 month: 3.26%
• 3 months: 6.75%
• 6 months: 1.86%
• Year to date: -11.09%
• 1 year: -62.62%
• 5 years: -96.54%
• 10 years: -98.43%
• Sector: Healthcare
• Industry: Biotechnology

About: ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Employees: 17